Galantamine 4 mg Tablet, single dose

DRUG2 trials

Sponsors

Actavis Inc.

Conditions

Healthy

Phase 1

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions

CompletedNCT01190761

Actavis Inc.Healthy

Start: 2004-12-31End: 2004-12-31Updated: 2010-08-30

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions

CompletedNCT01190748

Actavis Inc.Healthy

Start: 2004-11-30End: 2004-12-31Updated: 2024-02-22